Salus Financial Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$221K Sell
904
-66
-7% -$15.4K 0.13% 34
2025
Q4
$201K Buy
+970
New +$192K 0.12% 35

Other funds holding JNJ

Salus Financial Advisors's JNJ Position: Q1 2026 in Review

Salus Financial Advisors reduced its Johnson & Johnson (JNJ) stake by 6.8% in Q1 2026, selling an estimated $15.4K and leaving 904 shares worth $221K. The position accounts for 0.13% of the portfolio, ranked #34.

Salus Financial Advisors first reported a position in JNJ in Q4 2025 and has held it in 2 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Salus Financial Advisors held 904 shares of Johnson & Johnson worth $221K as of Q1 2026.
  • Salus Financial Advisors sold 66 Johnson & Johnson shares in Q1 2026, an estimated $15.4K.
  • Johnson & Johnson made up 0.13% of Salus Financial Advisors's portfolio in Q1 2026, its #34 holding.
  • Salus Financial Advisors first reported a position in Johnson & Johnson in Q4 2025 and has held it in 2 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Salus Financial Advisors's 13F filing for Q1 2026, filed 23 Apr 2026.